Lotus Pharm vs BIONIME: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and BIONIME (4737) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ BIONIME

0%+226%-29%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYBIONIMEYoY
Oct 2026NT$2.13 billion-22.5%NT$154.1 million+12.2%
Sep 2026NT$2.77 billion+128.0%NT$180 million+20.9%
Aug 2026NT$2.11 billion+81.7%NT$150 million-10.3%
Jul 2026NT$2.49 billion+3.9%NT$145.7 million+2.4%
Jun 2026NT$3.4 billion+225.5%NT$143.6 million-6.5%
May 2026NT$2.32 billion+105.8%NT$141.7 million-13.5%
Apr 2026NT$3.09 billion+19.9%NT$141.3 million-8.4%
Mar 2026NT$4.35 billion+173.6%NT$167.5 million+4.7%
Feb 2026NT$2.24 billion+131.5%NT$110.6 million-28.9%
Jan 2026NT$2.05 billion-5.5%NT$127.2 million-23.3%
Dec 2025NT$2.44 billion+66.9%NT$160.9 million+12.8%
Nov 2025NT$1.06 billion-0.2%NT$128.7 million-29.1%
Oct 2025NT$2.75 billion+46.0%NT$137.3 million-22.8%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16